A Systematic Review and Meta-Analysis of the Effect of Pentagalloyl Glucose Administration on Aortic Expansion in Animal Models.
abdominal aortic aneurysm
aortic aneurysm
pentagalloyl glucose
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
11 Oct 2021
11 Oct 2021
Historique:
received:
24
09
2021
revised:
08
10
2021
accepted:
08
10
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
Statut:
epublish
Résumé
The aim of this systematic review was to pool evidence from studies testing if pentagalloyl glucose (PGG) limited aortic expansion in animal models of abdominal aortic aneurysm (AAA). The review was conducted according to the PRISMA guidelines and registered with PROSPERO. The primary outcome was aortic expansion assessed by direct measurement. Secondary outcomes included aortic expansion measured by ultrasound and aortic diameter at study completion. Sub analyses examined the effect of PGG delivery in specific forms (nanoparticles, periadventitial or intraluminal), and at different times (from the start of AAA induction or when AAA was established), and tested in different animals (pigs, rats and mice) and AAA models (calcium chloride, periadventitial, intraluminal elastase or angiotensin II). Meta-analyses were performed using Mantel-Haenszel's methods with random effect models and reported as mean difference (MD) and 95% confidence intervals (CIs). Risk of bias was assessed with a customized tool. Eleven studies reported in eight publications involving 214 animals were included. PGG significantly reduced aortic expansion measured by direct observation (MD: -66.35%; 95% CI: -108.44, -24.27; There is inconsistent low-quality evidence that PGG inhibits aortic expansion in animal models.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of this systematic review was to pool evidence from studies testing if pentagalloyl glucose (PGG) limited aortic expansion in animal models of abdominal aortic aneurysm (AAA).
METHODS
METHODS
The review was conducted according to the PRISMA guidelines and registered with PROSPERO. The primary outcome was aortic expansion assessed by direct measurement. Secondary outcomes included aortic expansion measured by ultrasound and aortic diameter at study completion. Sub analyses examined the effect of PGG delivery in specific forms (nanoparticles, periadventitial or intraluminal), and at different times (from the start of AAA induction or when AAA was established), and tested in different animals (pigs, rats and mice) and AAA models (calcium chloride, periadventitial, intraluminal elastase or angiotensin II). Meta-analyses were performed using Mantel-Haenszel's methods with random effect models and reported as mean difference (MD) and 95% confidence intervals (CIs). Risk of bias was assessed with a customized tool.
RESULTS
RESULTS
Eleven studies reported in eight publications involving 214 animals were included. PGG significantly reduced aortic expansion measured by direct observation (MD: -66.35%; 95% CI: -108.44, -24.27;
CONCLUSION
CONCLUSIONS
There is inconsistent low-quality evidence that PGG inhibits aortic expansion in animal models.
Identifiants
pubmed: 34680560
pii: biomedicines9101442
doi: 10.3390/biomedicines9101442
pmc: PMC8533208
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cochrane Database Syst Rev. 2015 Feb 08;(2):CD001835
pubmed: 25927098
J Vasc Surg. 2018 Jan;67(1):2-77.e2
pubmed: 29268916
Sci Rep. 2021 Apr 21;11(1):8584
pubmed: 33883612
Circulation. 2007 Apr 3;115(13):1729-37
pubmed: 17372168
Lancet. 2015 Jan 10;385(9963):117-71
pubmed: 25530442
Theranostics. 2016 Aug 18;6(11):1975-1987
pubmed: 27698934
BMC Med Res Methodol. 2014 Mar 26;14:43
pubmed: 24667063
JAMA. 2002 Jun 12;287(22):2968-72
pubmed: 12052126
J Clin Epidemiol. 2000 Nov;53(11):1119-29
pubmed: 11106885
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
J Cardiovasc Transl Res. 2016 Dec;9(5-6):445-455
pubmed: 27542007
Eur J Vasc Endovasc Surg. 2020 Sep;60(3):452-460
pubmed: 32703634
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Clin Med. 2021 Jan 09;10(2):
pubmed: 33435461
Heart. 2021 Sep;107(18):1465-1471
pubmed: 33199361
Nat Rev Cardiol. 2019 Apr;16(4):225-242
pubmed: 30443031
J Vasc Surg. 2019 Sep;70(3):954-969.e30
pubmed: 31147117
Exp Mech. 2021 Jan;61(1):41-51
pubmed: 33746235
J Intern Med. 2020 Jul;288(1):6-22
pubmed: 31278799
Bioengineering (Basel). 2019 Jul 03;6(3):
pubmed: 31277241
Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93
pubmed: 30528142
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Ann Biomed Eng. 2019 Jan;47(1):39-59
pubmed: 30298373
PLoS One. 2020 Mar 27;15(3):e0227165
pubmed: 32218565
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1504-1517
pubmed: 33567871
ACS Appl Mater Interfaces. 2021 Jun 9;13(22):25771-25782
pubmed: 34030437
PLoS One. 2020 Aug 28;15(8):e0234409
pubmed: 32857766
JAMA Cardiol. 2020 Dec 1;5(12):1374-1381
pubmed: 32845283
J Am Heart Assoc. 2018 Oct 2;7(19):e009866
pubmed: 30371299
Ann Med Surg (Lond). 2016 Mar 23;7:65-70
pubmed: 27144001
Eur Radiol. 2008 Sep;18(9):1987-94
pubmed: 18414871